Rhythm reports Q2 2026 IMCIVREE revenue of $71.3 million, strong HO launch uptakeAug 4Regulatory decisionRhythm Pharmaceuticals, Inc.setmelanotide
Rhythm Pharmaceuticals is collaborator on new German real-world setmelanotide study in BBSJun 29Trial updateRhythm Pharmaceuticals, Inc.setmelanotide
Sign inSign in